4.8 Article

Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 366, Issue 24, Pages 2276-2283

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/nejmoa1201356

Keywords

-

Funding

  1. U.K. National Health Service
  2. University College London
  3. U.K. Medical Research Council [G7900510, MR/K000187/1]
  4. Wolfson Foundation
  5. Cariplo Foundation [2009-2543]
  6. Italian Ministry of University and Research [FIRB RBFR109EOS, PRIN 20083ERXWS]
  7. MRC [G7900510, MR/K000187/1] Funding Source: UKRI
  8. Medical Research Council [G7900510, MR/K000187/1] Funding Source: researchfish

Ask authors/readers for more resources

We describe a kindred with slowly progressive gastrointestinal symptoms and autonomic neuropathy caused by autosomal dominant, hereditary systemic amyloidosis. The amyloid consists of Asp76Asn variant beta(2)-microglobulin. Unlike patients with dialysis-related amyloidosis caused by sustained high plasma concentrations of wild-type beta(2)-microglobulin, the affected members of this kindred had normal renal function and normal circulating beta 2-microglobulin values. The Asp76Asn beta(2)-microglobulin variant was thermodynamically unstable and remarkably fibrillogenic in vitro under physiological conditions. Previous studies of beta(2)-microglobulin aggregation have not shown such amyloidogenicity for single-residue substitutions. Comprehensive biophysical characterization of the beta(2)-microglobulin variant, including its 1.40-angstrom, three-dimensional structure, should allow further elucidation of fibrillogenesis and protein misfolding.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available